NYSEAMERICAN:BVX - Bovie Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$4.03 +0.01 (+0.25 %)
(As of 06/22/2018 02:56 PM ET)
Previous Close$4.00
Today's Range$3.93 - $4.06
52-Week Range$2.17 - $4.29
Volume2,211 shs
Average Volume83,461 shs
Market Capitalization$76.91 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.75
Bovie Medical logoBovie Medical Corporation, a medical device company, develops, manufactures, and markets electrosurgical devices and technologies, and related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It also offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians in the areas of gynecology, general surgery, and urology. In addition, the company provides battery operated cauteries for precise hemostasis in ophthalmology; nerve locator stimulator primarily used for identifying motor nerves in hand and facial reconstructive surgery; penlights for use in offices; and specialty lighting instruments for use in ophthalmology, as well as distributes specialty lighting instruments for general surgery, hip replacement surgery, and endotracheal tubes placement. Further, it develops J-Plasma, a patented helium-based plasma surgical product, as well as designs, develops, and manufactures electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing agreements. Bovie Medical Corporation markets its products to distributors under own brands, such as Bovie, IDS, and DERM, as well as under a private label. The company was formerly known as An-Con Genetics Inc. and changed its name to Bovie Medical Corporation in October 1998. Bovie Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Receive BVX News and Ratings via Email

Sign-up to receive the latest news and ratings for BVX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:BVX
CUSIPN/A
Phone+1-727-3842323

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-13.32%
Return on Equity-21.67%
Return on Assets-15.79%

Miscellaneous

EmployeesN/A
Outstanding Shares32,880,000

Bovie Medical (NYSEAMERICAN:BVX) Frequently Asked Questions

What is Bovie Medical's stock symbol?

Bovie Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BVX."

How were Bovie Medical's earnings last quarter?

Bovie Medical Co. (NYSEAMERICAN:BVX) announced its quarterly earnings data on Monday, May, 14th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.02) by $0.01. The medical device company had revenue of $9.92 million for the quarter. Bovie Medical had a negative net margin of 13.32% and a negative return on equity of 21.67%. View Bovie Medical's Earnings History.

When is Bovie Medical's next earnings date?

Bovie Medical is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for Bovie Medical.

Are investors shorting Bovie Medical?

Bovie Medical saw a drop in short interest during the month of May. As of May 15th, there was short interest totalling 115,200 shares, a drop of 32.0% from the April 30th total of 169,409 shares. Based on an average daily trading volume, of 110,248 shares, the days-to-cover ratio is presently 1.0 days. Approximately 0.4% of the company's shares are short sold. View Bovie Medical's Current Options Chain.

Who are some of Bovie Medical's key competitors?

Who are Bovie Medical's key executives?

Bovie Medical's management team includes the folowing people:
  • Mr. Charles D. Goodwin II, CEO & Director
  • Mr. J. Robert Saron, Pres, Chief Sales & Marketing Officer and Director (Age 65)
  • Mr. Jay D. Ewers CPA, CFO, Treasurer & Sec. (Age 57)
  • Mr. Moshe Citronowicz, Sr. VP (Age 65)
  • Mr. Todd Hornsby, VP & GM of Advanced Energy

Has Bovie Medical been receiving favorable news coverage?

News stories about BVX stock have trended somewhat positive this week, according to Accern Sentiment. Accern ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Bovie Medical earned a media sentiment score of 0.17 on Accern's scale. They also gave headlines about the medical device company an impact score of 45.71 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are Bovie Medical's major shareholders?

Bovie Medical's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Archon Capital Management LLC (6.89%), Millrace Asset Group Inc. (1.92%), Cortina Asset Management LLC (1.90%) and Cowen Prime Services LLC (0.96%). View Institutional Ownership Trends for Bovie Medical.

Which institutional investors are selling Bovie Medical stock?

BVX stock was sold by a variety of institutional investors in the last quarter, including Cortina Asset Management LLC. View Insider Buying and Selling for Bovie Medical.

Which institutional investors are buying Bovie Medical stock?

BVX stock was bought by a variety of institutional investors in the last quarter, including Archon Capital Management LLC, Millrace Asset Group Inc. and Cowen Prime Services LLC. View Insider Buying and Selling for Bovie Medical.

How do I buy shares of Bovie Medical?

Shares of BVX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bovie Medical's stock price today?

One share of BVX stock can currently be purchased for approximately $3.93.

How big of a company is Bovie Medical?

Bovie Medical has a market capitalization of $76.91 million.

How can I contact Bovie Medical?

Bovie Medical's mailing address is 4 Manhattanville Rd Ste 106, PURCHASE, NY 10577-2119, United States. The medical device company can be reached via phone at +1-727-3842323.


MarketBeat Community Rating for Bovie Medical (BVX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  78 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  171
MarketBeat's community ratings are surveys of what our community members think about Bovie Medical and other stocks. Vote "Outperform" if you believe BVX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BVX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.